NDC-11 (Package) | NDC-9 (Product) | Generic Name | Brand Name | Strength | SEER*Rx Category | Major Class | Minor Class | Administration Route | Package Effective Date | Package Discontinuation Date | Status (Descending) |
---|---|---|---|---|---|---|---|---|---|---|---|
10019-0906-63 | 10019-0906 | Ondansetron | Ondansetron | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Intramuscular, Intravenous | Nov. 19, 2010 | July 31, 2013 | No Longer Used | |
16714-0522-01 | 16714-0522 | Finasteride | Finasteride | Ancillary Therapy | Protective Agent | 5-alpha Reductase Inhibitor | Oral | March 4, 2011 | Feb. 28, 2015 | No Longer Used | |
16714-0522-02 | 16714-0522 | Finasteride | Finasteride | Ancillary Therapy | Protective Agent | 5-alpha Reductase Inhibitor | Oral | March 2, 2011 | March 4, 2011 | No Longer Used | |
16714-0522-03 | 16714-0522 | Finasteride | Finasteride | Ancillary Therapy | Protective Agent | 5-alpha Reductase Inhibitor | Oral | March 2, 2011 | Feb. 28, 2015 | No Longer Used | |
16714-0522-04 | 16714-0522 | Finasteride | Finasteride | Ancillary Therapy | Protective Agent | 5-alpha Reductase Inhibitor | Oral | March 2, 2011 | Feb. 28, 2015 | No Longer Used | |
16714-0522-05 | 16714-0522 | Finasteride | Finasteride | Ancillary Therapy | Protective Agent | 5-alpha Reductase Inhibitor | Oral | March 4, 2011 | Feb. 28, 2015 | No Longer Used | |
16714-0522-10 | 16714-0522 | Finasteride | Finasteride | Ancillary Therapy | Protective Agent | 5-alpha Reductase Inhibitor | Oral | Sept. 19, 2012 | Aug. 31, 2014 | No Longer Used | |
36000-0012-05 | 36000-0012 | Ondansetron Hydrochloride | Ondansetron Hydrochloride | 2.0 mg/mL | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Intramuscular, Intravenous | March 13, 2013 | May 10, 2013 | No Longer Used |
36000-0012-25 | 36000-0012 | Ondansetron Hydrochloride | Ondansetron Hydrochloride | 2.0 mg/mL | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Intramuscular, Intravenous | March 13, 2013 | No Longer Used | |
00069-9144-11 | 00069-9144 | Docetaxel | Docetaxel | 200.0 mg/20mL | Chemotherapy | Antimitotic Agent | Taxane | Intravenous | June 23, 2014 | April 30, 2017 | No Longer Used |
00069-9144-22 | 00069-9144 | Docetaxel | Docetaxel | 200.0 mg/20mL | Chemotherapy | Antimitotic Agent | Taxane | Intravenous | June 23, 2014 | Feb. 20, 2015 | No Longer Used |
00409-0369-01 | 00409-0369 | Docetaxel | Docetaxel | 20.0 mg/mL | Chemotherapy | Antimitotic Agent | Taxane | Intravenous | March 28, 2017 | March 28, 2017 | No Longer Used |
55513-0014-01 | 55513-0014 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Oct. 1, 2001 | Feb. 28, 2009 | No Longer Used | |||
55513-0015-01 | 55513-0014 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Aug. 19, 2002 | April 30, 2009 | No Longer Used | |||
55513-0039-01 | 55513-0039 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Feb. 18, 2011 | Feb. 28, 2009 | No Longer Used | |||
55513-0039-04 | 55513-0039 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | July 23, 2003 | Feb. 28, 2009 | No Longer Used | |||
55513-0041-01 | 55513-0041 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Feb. 18, 2011 | Feb. 28, 2009 | No Longer Used | |||
55513-0041-04 | 55513-0041 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | July 23, 2003 | Feb. 28, 2009 | No Longer Used | |||
55513-0043-01 | 55513-0043 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Feb. 18, 2011 | Dec. 31, 2008 | No Longer Used | |||
55513-0043-04 | 55513-0043 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | June 1, 2004 | Dec. 31, 2008 | No Longer Used | |||
55513-0044-01 | 55513-0044 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Feb. 18, 2011 | Feb. 28, 2009 | No Longer Used | |||
55513-0044-04 | 55513-0044 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | July 23, 2003 | Feb. 28, 2009 | No Longer Used | |||
55513-0046-01 | 55513-0046 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Feb. 18, 2011 | April 30, 2009 | No Longer Used | |||
55513-0046-04 | 55513-0046 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | July 23, 2003 | April 30, 2009 | No Longer Used | |||
51079-0520-01 | 51079-0520 | Finasteride | Finasteride | 5.0 mg/1 | Ancillary Therapy | Protective Agent | 5-alpha Reductase Inhibitor | Oral | Oct. 22, 2007 | Aug. 31, 2015 | No Longer Used |
Found 10,000 results in 4 milliseconds — Export these results